Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells.

Oncol Lett · 2022 · PMC8721864 · PMID 34992683

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In the MBCD3 cells, Bcl-2 expression was elevated by paclitaxel in an increasing trend from 1 to 10 μg/ml, and at the highest dose (50 μg/ml), dropped to 1.7 fold-change difference.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.